A study to investigate the analgesic efficacy of AZD2423 compared with placebo after 28 days treatment in patients with posttraumatic neuralgia..

Study identifier:D2600C00012

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A study to investigate the analgesic efficacy of AZD2423 compared with placebo after 28 days treatment in patients with posttraumatic neuralgia..

Medical condition

Nerve Pain

Phase

Phase 2

Healthy volunteers

No

Study drug

AZD2423, Placebo

Sex

All

Actual Enrollment

133

Study type

Interventional

Age

18 Years - 80 Years

Date

Study Start Date: 01 Oct 2010
Primary Completion Date: 01 Apr 2012
Study Completion Date: 01 Apr 2012

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Jul 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria